Tiagabine
Back to searchMolecule Structure
Scientific Name
Tiagabine
Description of the Drug
Tiagabine is an antiepileptic used to treat partial seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00906
http://www.drugbank.ca/drugs/DB00906
Brand Name(s)
Gabitril
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Msn Laboratories Private Ltd, Cephalon Inc, Wilshire Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA transporter 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1903 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34653 | ||
PharmGKB | PA451682 | ||
Human Metabolome Database | HMDB0015042 | ||
DrugBank | DB00906 | ||
PubChem: Thomson Pharma | 14804309 | 14926800 | |
PubChem | 40467242 | 60648 | |
LINCS | LSM-5700 | ||
Nikkaji | J390.632I | ||
PDBe | TGI | ||
BindingDB | 50039251 | 50368628 | |
EPA CompTox Dashboard | DTXSID5023663 | ||
DrugCentral | 2648 | ||
Guide to Pharmacology | 4685 | 4818 | |
rxnorm | TIAGABINE HYDROCHLORIDE | TIAGABINE | GABITRIL |
KEGG Ligand | C07503 | ||
ChEBI | 9586 | ||
ZINC | ZINC000003831531 |